Rena M Conti

Learn More
OBJECTIVE The authors examined trends in the use of second-generation antipsychotics for treatment of bipolar disorder before and after the U.S. Food and Drug Administration's approval in 2000 of olanzapine for use in treating acute manic episodes of bipolar disorder. METHODS The IMS Health National Disease and Therapeutic Index was used to derive monthly(More)
Prior research has shown that demand shocks for medical products spur additional product development. These studies do not distinguish between innovative products and those that largely duplicate existing options. We explore the impact of the introduction of Medicare Part D on the development of new biotechnology products. The law spurred research into(More)
OBJECTIVE Concerns have been raised that antidepressants may be overused. This study aimed to provide an estimate of antidepressant overuse in a more recent, nationally representative sample of adults and with a more contemporary set of antidepressants than has been covered in prior studies. METHODS The data set included adult (weighted N=23,026,608)(More)
  • Keith M Drake, Martha A Starr, Thomas Mcguire, Abu Speitan, Mike Augusteijn, Sebastian Bauhoff +19 others
  • 2014
We are grateful to Bennett Erickson and Addison Wood for expert help with data preparation and analysis, and to Laura Panattoni and session participants at the June, 2014 American Society of Heath Economics meetings for valuable comments on an earlier version of the paper. We also thank Moneil for insightful comments and suggestions. Responsibility for the(More)
OBJECTIVE This study assessed the effect of public health advisories issued between 2005 and 2007 by the U.S. Food and Drug Administration (FDA) on treatments of attention-deficit hyperactivity disorder (ADHD) and physician prescribing practices. METHODS Data obtained from the IMS Health National Disease and Therapeutic Index, a nationally representative(More)
  • 1